COMPANY
Clinical Phase 2
Keywords: ophthalmology eye diseases corneal disease Corneal Edema Fuchs Dystrophy Corneal Endothelial Cell Loss Pseudophakic Bullous Keratopathy Fuchs Fuchs' Endothelial Dystrophy Endothelial Corneal Dystrophy Corneal Endothelial Decompensation Corneal Endothelial Disorder Corneal Endothelial Dystrophy 1 Corneal Endothelial Dysfunction Corneal Endothelial Dystrophy Fuchs Endothelial Corneal Dystrophy Bullous Keratopathy Endothelial Dysfunction Moderate Corneal Endothelial Decompensation EO2002
Location: Menlo Park, CA · source · Oct 15, 2026
Profile checked Oct 10, 2026
Timeline
- Trial start Phase 2: Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction source ↗
- Trial start Phase 1: Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema source ↗
Upcoming milestones
- 2027-08 (ESTIMATED) · Phase 2 · Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction · NCT07729137
Estimated primary completion per ClinicalTrials.gov. Dates move.
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|
| NCT07729137 | Study of EO2002 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction | Phase 2 | Recruiting | 2026-10 | 2027-08 (estimated) |
| NCT04894110 | Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema | Phase 1 | Completed | Jun 22, 2021 | Oct 3, 2024 (actual) |
